Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-06-10
2008-06-10
Anderson, Rebecca (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S291000, C514S337000, C514S365000, C514S374000, C514S443000, C514S450000, C514S454000, C514S463000, C514S468000
Reexamination Certificate
active
07384947
ABSTRACT:
This invention relates to a novel fused tricyclic heterocycle of the formulaand its use for the treatment of hyper-proliferative disorders.
REFERENCES:
patent: 5466810 (1995-11-01), Godfrey
patent: 5504213 (1996-04-01), Fischer et al.
patent: 5565488 (1996-10-01), Braunlich et al.
patent: 5622989 (1997-04-01), Braunlich et al.
patent: 5691359 (1997-11-01), Fischer et al.
patent: 5922740 (1999-07-01), Braunlich et al.
patent: 0551662 (1993-07-01), None
patent: 0731099 (1996-09-01), None
patent: 0885893 (1998-12-01), None
patent: 9802440 (1998-01-01), None
patent: 0069841 (2000-11-01), None
patent: 0069842 (2000-11-01), None
patent: 0069843 (2000-11-01), None
patent: 0069844 (2000-11-01), None
Golub et al. Science 1999, 286, 531-537.
Takahashi et al. Science 1989, 246, 491-494.
; Liu et al. J. Thoracic Oncology 2006, 1(8), 771-779.
Liu et al. Oncogene 2004, 23, 6316-6324.
Patent Abstracts of Japan. vol. 009, No. 205 (C-299), Aug. 22, 1985 and JP 60 072880 A (Kaken Seiyaku KK), Apr. 24, 1985.
Hayakawa, et al., “4-Hydroxy-3-Methyl-6-Phenylbenzofuran-2-Carboxylic Acid Ethyl Ester Derivatives as Potent Anti-Tumor Agents,”Bioorg. Med. Chem. Lett., 14, 455-458 (2004).
Hayakawa, et al., “A Library Synthesis of 4-Hydroxy-3-Methyl-6-Phenylbenzofuran-2-Carboxylic Acid Ethyl Ester Derivatives as Anti-Tumor Agents,”Bioorg. Med. Chem. Lett., 14, 4383-4387 (2004).
Hayakawa, et al., “Thienopyridine and Benzofuran Derivatives as Potent Anti-Tumor Agents Possessing Different Structure-Activity Relationships,”Bioorg. Med. Chem. Lett., 14, 3411-3414 (2004).
Burke Michael
Chen Zhi
Dumas Jacques
Fan Dongping
Jones Benjamin D.
Anderson Rebecca
Bayer Healthcare LLC
Edwards Angell Palmer & & Dodge LLP
Kramer Barry
Nolan Jason M
LandOfFree
Fused tricyclic heterocycles useful for treating... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fused tricyclic heterocycles useful for treating..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused tricyclic heterocycles useful for treating... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2813646